Thomas E. Chorman, a director at Standex International Corp. (NASDAQ:SXI), recently sold 50 shares of common stock on June 1, 2026. The total value realized from this divestiture was $13,641, with each share selling at a price of $272.82.
It is important to note that this transaction was executed under the framework of a pre-arranged trading plan, specifically a 10b5-1 plan, which had been established on November 6, 2025. Following the sale of these shares, Mr. Chorman’s remaining direct holding in Standex International common stock stands at 12,466 shares.
The timing of this reported sale is notable given current market conditions for SXI. The stock was trading near its 52-week high of $292.98, and the share price at the time was $288.66, which represents a significant increase compared to the $272.82 sale price. Furthermore, the stock has shown substantial performance over the past year, achieving a reported return of 92.6%. An assessment provided by InvestingPro indicates that, relative to its Fair Value, the stock appears to be overvalued, classifying it among companies identified as being highly overvalued.
Beyond the insider trading activity, Standex International Corporation released its financial results for fiscal third-quarter 2026. The earnings report revealed a minor shortfall against market expectations on both key metrics: earnings per share (EPS) and revenue forecasts. Specifically, the company posted an EPS of $2.21, which was slightly below the predicted forecast of $2.23. Similarly, total revenue reached $224.6 million, missing the anticipated figure of $225.76 million.
Despite these deviations from forecasts, the underlying operational performance demonstrated positive momentum. Standex reported an 8.1% increase in total revenue when compared to year-over-year figures. In related corporate developments, Ademir Sarcevic was promoted to the role of Executive Vice President-Corporate and Group President-Electronics. In this expanded capacity, Mr. Sarcevic will assume oversight for the company’s Electronics segment and manage certain corporate projects. He continues his duties as Chief Financial Officer until a successor is appointed.
The combination of these recent events highlights several facets of Standex's current operational status and financial trajectory. The leadership adjustments, particularly the elevation of Mr. Sarcevic into multiple senior roles, underscore ongoing internal corporate restructuring within the company. Financially, while the Q3 2026 results indicate a slight underperformance against analyst expectations for both EPS and revenue, the year-over-year growth in total revenue remains a key indicator of sustained operational activity.
Risks
- The reported financial miss on Q3 2026 EPS and revenue forecasts could signal temporary operational headwinds or increased market scrutiny.
- The valuation concerns raised by InvestingPro, which classifies the stock as overvalued relative to its Fair Value, present a potential risk of correction among investors.
- Reliance on pre-arranged trading plans for insider sales, while compliant, means that subsequent price movements may not account for planned liquidity events.
More from Insider Trading
Risks
- The reported financial miss on Q3 2026 EPS and revenue forecasts could signal temporary operational headwinds or increased market scrutiny.
- The valuation concerns raised by InvestingPro, which classifies the stock as overvalued relative to its Fair Value, present a potential risk of correction among investors.
- Reliance on pre-arranged trading plans for insider sales, while compliant, means that subsequent price movements may not account for planned liquidity events.